PRECIGEN, INC. Increase (Decrease) in Deferred Revenue
PRECIGEN, INC. (PGEN) reported Increase (Decrease) in Deferred Revenue of -$15.65 million for the 6-month period ending 2018-06-30, per its 10-Q filed 2018-08-13.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredRevenue · last filed 2018-08-13
- PRECIGEN, INC. increase (decrease) in deferred revenue for the quarter ending 2018-06-30 was -$6.03M.
- PRECIGEN, INC. increase (decrease) in deferred revenue for the quarter ending 2018-03-31 was -$9.62M.
- PRECIGEN, INC. increase (decrease) in deferred revenue for the quarter ending 2017-12-31 was -$40.06M.
- PRECIGEN, INC. increase (decrease) in deferred revenue for the quarter ending 2017-09-30 was -$9.49M.
- PRECIGEN, INC. increase (decrease) in deferred revenue for fiscal 2017 was -$75.34M.
- PRECIGEN, INC. increase (decrease) in deferred revenue for fiscal 2016 was -$25.48M, a 134.23% decline from fiscal 2015.
- PRECIGEN, INC. increase (decrease) in deferred revenue for fiscal 2015 was $74.43M, a 255.57% increase from fiscal 2014.
- PRECIGEN, INC. increase (decrease) in deferred revenue for fiscal 2014 was $20.93M.
| Period end | Increase (Decrease) in Deferred Revenue 3 month | Increase (Decrease) in Deferred Revenue 3 month as first filed | Increase (Decrease) in Deferred Revenue 6 month | Increase (Decrease) in Deferred Revenue 9 month | Increase (Decrease) in Deferred Revenue 12 month |
|---|---|---|---|---|---|
| 2018-06-30 | -$6.03M derived: 10-Q 6 month − 10-Q/A 3 month · filed 2018-08-13 | -$15.65M 10-Q · filed 2018-08-13 | -$55.70M derived: sum of 3 quarters · filed 2018-08-13 | -$65.19M derived: sum of 4 quarters · filed 2018-08-13 | |
| 2018-03-31 | -$9.62M 10-Q/A · filed 2018-08-13 | -$13.80M 10-Q · filed 2018-05-10 | -$49.68M derived: sum of 2 quarters · filed 2018-08-13 | -$59.17M derived: sum of 3 quarters · filed 2018-08-13 | -$71.95M derived: sum of 4 quarters · filed 2018-08-13 |
| 2017-12-31 | -$40.06M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | -$49.54M derived: sum of 2 quarters · filed 2018-03-01 | -$62.33M derived: sum of 3 quarters · filed 2018-08-13 | -$75.34M 10-K · filed 2018-03-01 | |
| 2017-09-30 | -$9.49M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | -$22.27M derived: sum of 2 quarters · filed 2018-08-13 | -$35.28M 10-Q · filed 2017-11-09 | -$46.66M derived: sum of 4 quarters · filed 2018-08-13 | |
| 2017-06-30 | -$12.78M derived: 10-Q 6 month − 10-Q/A 3 month · filed 2018-08-13 | -$25.79M 10-Q · filed 2018-08-13 | -$37.18M derived: sum of 3 quarters · filed 2018-08-13 | -$45.20M derived: sum of 4 quarters · filed 2018-08-13 | |
| 2017-03-31 | -$13.01M 10-Q/A · filed 2018-08-13 | -$24.39M derived: sum of 2 quarters · filed 2018-08-13 | -$32.41M derived: sum of 3 quarters · filed 2018-08-13 | -$41.54M derived: sum of 4 quarters · filed 2018-08-13 | |
| 2016-12-31 | -$11.38M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | -$19.40M derived: sum of 2 quarters · filed 2018-03-01 | -$28.53M derived: sum of 3 quarters · filed 2018-03-01 | -$25.48M 10-K · filed 2018-03-01 | |
| 2016-09-30 | -$8.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | -$17.15M derived: sum of 2 quarters · filed 2017-11-09 | -$14.10M 10-Q · filed 2017-11-09 | $7.93M derived: sum of 4 quarters · filed 2018-03-01 | |
| 2016-06-30 | -$9.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | -$6.08M 10-Q · filed 2017-08-09 | $15.96M derived: sum of 3 quarters · filed 2018-03-01 | $7.45M derived: sum of 4 quarters · filed 2018-03-01 | |
| 2016-03-31 | $3.05M 10-Q · filed 2017-05-10 | $25.08M derived: sum of 2 quarters · filed 2018-03-01 | $16.57M derived: sum of 3 quarters · filed 2018-03-01 | $80.11M derived: sum of 4 quarters · filed 2018-03-01 | |
| 2015-12-31 | $22.03M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $13.53M derived: sum of 2 quarters · filed 2018-03-01 | $77.06M derived: sum of 3 quarters · filed 2018-03-01 | $74.43M 10-K · filed 2018-03-01 | |
| 2015-09-30 | -$8.51M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $55.02M derived: sum of 2 quarters · filed 2016-11-09 | $52.40M 10-Q · filed 2016-11-09 | $54.70M derived: sum of 4 quarters · filed 2017-03-01 | |
| 2015-06-30 | $63.53M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $60.91M 10-Q · filed 2016-08-09 | $63.21M derived: sum of 3 quarters · filed 2017-03-01 | $61.19M derived: sum of 4 quarters · filed 2017-03-01 | |
| 2015-03-31 | -$2.62M 10-Q · filed 2016-05-10 | -$323.00K derived: sum of 2 quarters · filed 2017-03-01 | -$2.34M derived: sum of 3 quarters · filed 2017-03-01 | -$4.87M derived: sum of 4 quarters · filed 2017-03-01 | |
| 2014-12-31 | $2.30M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $277.00K derived: sum of 2 quarters · filed 2017-03-01 | -$2.25M derived: sum of 3 quarters · filed 2017-03-01 | $20.93M 10-K · filed 2017-03-01 | |
| 2014-09-30 | -$2.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | -$4.55M derived: sum of 2 quarters · filed 2015-11-09 | $18.64M 10-Q · filed 2015-11-09 | $20.36M derived: sum of 4 quarters · filed 2016-02-29 | |
| 2014-06-30 | -$2.53M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | $20.66M 10-Q · filed 2015-08-10 | $22.38M derived: sum of 3 quarters · filed 2016-02-29 | $13.98M derived: sum of 4 quarters · filed 2016-02-29 | |
| 2014-03-31 | $23.18M 10-Q · filed 2015-05-11 | $24.91M derived: sum of 2 quarters · filed 2016-02-29 | $16.50M derived: sum of 3 quarters · filed 2016-02-29 | $18.76M derived: sum of 4 quarters · filed 2016-02-29 | |
| 2013-12-31 | $1.72M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | -$6.68M derived: sum of 2 quarters · filed 2016-02-29 | -$4.42M derived: sum of 3 quarters · filed 2016-02-29 | -$4.37M 10-K · filed 2016-02-29 | |
| 2013-09-30 | -$8.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-13 | -$6.15M derived: sum of 2 quarters · filed 2014-11-13 | -$6.09M 10-Q · filed 2014-11-13 | -$5.96M derived: sum of 4 quarters · filed 2015-03-02 | |
| 2013-06-30 | $2.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14 | $2.31M 10-Q · filed 2014-08-14 | $2.44M derived: sum of 3 quarters · filed 2015-03-02 | $62.00K derived: sum of 4 quarters · filed 2015-03-02 | |
| 2013-03-31 | $56.00K 10-Q · filed 2014-05-09 | $186.00K derived: sum of 2 quarters · filed 2015-03-02 | -$2.19M derived: sum of 3 quarters · filed 2015-03-02 | ||
| 2012-12-31 | $130.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | -$2.25M derived: sum of 2 quarters · filed 2015-03-02 | $5.00M 10-K · filed 2015-03-02 | ||
| 2012-09-30 | -$2.38M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2013-11-07 | $4.87M 10-Q · filed 2013-11-07 | |||
| 2012-06-30 | $7.25M 10-Q/A · filed 2013-10-21 | ||||
| 2011-12-31 | -$2.25M 10-K · filed 2014-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NewAmsterdam Pharma Co N.V. (NAMS) | $2.719B | -15.37 | |
| MBX Biosciences, Inc. (MBX) | United States | $2.664B | -25.36 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Dyne Therapeutics, Inc. (DYN) | United States | $3.084B | -7.09 |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |